The prevalence of inflammatory bowel disease in U.S. children under 20 is increasing, with over 100,000 affected, revealing critical public health concerns.
Triastek and BioNTech to develop 3D printed RNA therapeutics
The collaboration is aimed at advancing oral RNA therapeutics with distinct external and internal geometries. Credit: Pickadook / Shutterstock. BioNTech and Triastek have entered a